Moderna and Mitsubishi Tanabe Pharma ink agreement to promote Moderna’s mRNA respiratory vaccine portfolio in Japan
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
AIIMS Jammu is a beacon of hope not only for the people of J&K, but also for that of Leh, and other neighboring states
The academy has secured partnerships with 15 esteemed hospitals
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Ibara will drive AI-powered clinical research innovation
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Subscribe To Our Newsletter & Stay Updated